Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-08-09 7:06 pm Sale | 13D | Passage BIO Inc. PASG | Versant Venture Capital VI L.P. | 0 0.000% | -4,026,417 (Position Closed) | View |
| 2024-08-09 5:15 pm Purchase | 13G | Passage BIO Inc. PASG | Lynx1 Capital Management LP | 8,426,955 13.600% | 3,581,084 (+73.90%) | View |
| 2024-05-29 4:35 pm Unchanged | 13D | Passage BIO Inc. PASG | Versant Venture Capital VI L.P. | 4,026,417 6.500% | 0 (Unchanged) | View |
| 2024-04-12 5:35 pm Unchanged | 13D | Passage BIO Inc. PASG | ORBIMED ADVISORS LLC | 8,034,000 13.000% | 0 (Unchanged) | View |
| 2024-03-29 4:15 pm Purchase | 13G | Passage BIO Inc. PASG | Lynx1 Capital Management LP | 4,845,871 8.700% | 4,466,712 (+1178.06%) | View |
| 2024-02-14 09:21 am Sale | 13G | Passage BIO Inc. PASG | Lynx1 Capital Management LP | 379,159 0.700% | -2,976,758 (-88.70%) | View |
| 2023-11-09 5:27 pm Unchanged | 13D | Passage BIO Inc. PASG | Versant Venture Capital VI L.P. | 4,026,417 7.300% | 0 (Unchanged) | View |
| 2023-06-29 4:36 pm Purchase | 13D | Passage BIO Inc. PASG | ORBIMED ADVISORS LLC | 8,034,000 14.700% | 1,192,577 (+17.43%) | View |
| 2023-06-15 10:25 am Sale | 13D | Passage BIO Inc. PASG | Frazier Life Sciences IX L.P. | 2,543,698 4.700% | -1,213,217 (-32.29%) | View |
| 2023-02-14 4:06 pm Purchase | 13G | Passage BIO Inc. PASG | Lynx1 Capital Management LP | 3,355,917 6.200% | 603,495 (+21.93%) | View |
| 2023-02-14 08:53 am Sale | 13G | Passage BIO Inc. PASG | Deep Track Capital LP | 0 0.000% | -3,216,997 (Position Closed) | View |
| 2022-09-29 4:30 pm Purchase | 13G | Passage BIO Inc. PASG | Lynx1 Capital Management LP | 2,752,422 5.100% | 2,752,422 (New Position) | View |
| 2022-08-15 11:29 am Sale | 13D | Passage BIO Inc. PASG | Frazier Life Sciences IX L.P. | 3,756,915 6.900% | -1,264,523 (-25.18%) | View |
| 2022-07-08 4:56 pm Sale | 13G | Passage BIO Inc. PASG | BlackRock Inc. BLK | 1,368,347 2.500% | -2,123,208 (-60.81%) | View |
| 2022-05-05 4:56 pm Purchase | 13D | Passage BIO Inc. PASG | ORBIMED ADVISORS LLC | 6,841,423 12.600% | 894,100 (+15.03%) | View |
| 2022-02-14 08:59 am Purchase | 13G | Passage BIO Inc. PASG | Deep Track Capital LP | 3,216,997 5.950% | 364,057 (+12.76%) | View |
| 2022-02-14 07:01 am Unchanged | 13G | Passage BIO Inc. PASG | Access Industries Holdings LLC | 2,616,630 4.800% | 0 (Unchanged) | View |
| 2022-02-09 12:22 pm Sale | 13G | Passage BIO Inc. PASG | LAV Prescience Ltd | 2,199,676 4.100% | -627,652 (-22.20%) | View |
| 2022-02-04 4:12 pm Purchase | 13G | Passage BIO Inc. PASG | BlackRock Inc. BLK | 3,491,555 6.500% | 3,491,555 (New Position) | View |
| 2021-12-10 08:52 am Sale | 13G | Passage BIO Inc. PASG | FMR LLC | 2,667,917 4.930% | -2,610,183 (-49.45%) | View |